Savant Capital LLC Sells 2,510 Shares of HCA Healthcare, Inc. $HCA

Savant Capital LLC reduced its stake in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 55.2% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 2,038 shares of the company’s stock after selling 2,510 shares during the period. Savant Capital LLC’s holdings in HCA Healthcare were worth $951,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in HCA. Brighton Jones LLC bought a new position in shares of HCA Healthcare in the 4th quarter worth about $1,021,000. NewEdge Advisors LLC raised its position in shares of HCA Healthcare by 11.9% in the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after acquiring an additional 409 shares in the last quarter. Sivia Capital Partners LLC raised its position in shares of HCA Healthcare by 5.5% in the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after acquiring an additional 33 shares in the last quarter. Jump Financial LLC bought a new position in shares of HCA Healthcare in the 2nd quarter worth about $2,073,000. Finally, Sei Investments Co. raised its position in shares of HCA Healthcare by 56.3% in the 2nd quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock worth $52,328,000 after acquiring an additional 49,214 shares in the last quarter. 62.73% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on HCA. Jefferies Financial Group reaffirmed a “buy” rating and issued a $525.00 target price on shares of HCA Healthcare in a research report on Friday, April 24th. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of HCA Healthcare in a research report on Wednesday, March 4th. Stephens decreased their target price on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. Truist Financial decreased their target price on HCA Healthcare from $546.00 to $535.00 and set a “buy” rating for the company in a research report on Monday, April 27th. Finally, Barclays decreased their target price on HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. Sixteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $515.77.

Check Out Our Latest Stock Analysis on HCA Healthcare

HCA Healthcare Stock Performance

HCA stock opened at $366.77 on Wednesday. The company has a market capitalization of $81.36 billion, a P/E ratio of 12.61, a price-to-earnings-growth ratio of 1.18 and a beta of 1.12. HCA Healthcare, Inc. has a 52-week low of $330.00 and a 52-week high of $556.52. The business has a 50-day simple moving average of $449.37 and a two-hundred day simple moving average of $480.24.

HCA Healthcare (NYSE:HCAGet Free Report) last released its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The company had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. HCA Healthcare’s revenue for the quarter was up 4.3% on a year-over-year basis. During the same quarter last year, the firm posted $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts forecast that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be paid a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s payout ratio is presently 10.73%.

HCA Healthcare Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

See Also

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.